A Study of Remternetug Versus Placebo in Early Alzheimer's Disease Participants at Risk for Cognitive and Functional Decline
Latest Information Update: 29 Oct 2024
At a glance
- Drugs Remternetug (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 25 Oct 2024 New trial record